Tempest Therapeutics Employee Directory

Tempest Therapeutics corporate office is located in 2000 Sierra Point Pkwy Ste 400, Brisbane, California, 94005, United States and has 1-10 employees.

Employees by Department

Departments

Number of employees

C-Suite

1

Engineering & Technical

1

Finance

1

Tempest Therapeutics CEO

Matt Angel, President & Chief Executive Officer at Tempest Therapeutics
United States flag for contact location.
Matt AngelPresident & Chief Executive Officer
PhonePhoneEmailEmail
See Profile

Key Employees of Tempest Therapeutics

Tempest Therapeutics Global Presence

globalPresence illustration
North America1-10
Asia1-10

Index of contact profiles from Tempest Therapeutics

Hundreds of professionals searching for Tempest Therapeutics have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12

Former Employees at Tempest Therapeutics

Explore people who held key positions, contributed to Tempest Therapeutics's success, and advanced their careers.

People from Similar Companies in the Business Services Industry Located in California, United States

Frequently Asked Questions Regarding Tempest Therapeutics Employees

How many employees does Tempest Therapeutics have?
Tempest Therapeutics has 1-10 employees
Who is the CEO of Tempest Therapeutics?
Tempest Therapeutics’s CEO is Matt Angel
Who are Tempest Therapeutics key employees?
Some of Tempest Therapeutics key employees are Robbie Starbody, Pearl Tay
Where is Tempest Therapeutics located?
Tempest Therapeutics’s headquarters are located at 2000 Sierra Point Pkwy Ste 400, Brisbane, California, 94005, United States
How do I contact Tempest Therapeutics?
Tempest Therapeutics Contact Info: Phone number: (415) 798-8589 Website: www.tempesttx.com
What does Tempest Therapeutics do?

Tempest Therapeutics is a clinical-stage biotechnology company headquartered in Brisbane, California, and publicly traded on Nasdaq under the ticker TPST. The company develops next-generation in vivo CAR-T therapies for autoimmune diseases and cancer, using a proprietary mRNA lipid nanoparticle delivery platform. Its pipeline includes TPST-4003, a... dual-target CD19/BCMA CAR-T therapy, and TPST-2003, a similar therapy being developed for relapsed/refractory multiple myeloma in partnership with Novatim Immune Therapeutics. Tempest is also exploring applications in conditions such as myasthenia gravis and multiple sclerosis.Read More

Is Tempest Therapeutics a public company?
Yes, Tempest Therapeutics is a public company and is traded under the symbol TPST
See more information about Tempest Therapeutics Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.